Market Tracker

12/09 5:16pm ET

Galapagos NV (NASDAQ:GLPG)

59.01
Delayed Data
As of 4:00pm ET
 +0.06 / +0.10%
Today’s Change
37.03
Today|||52-Week Range
73.37
-6.15%
Year-to-Date
Gilead Sciences, Inc.'s $10 Billion Mistake
Dec 01 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close58.95
Today’s open58.95
Day’s range58.45 - 59.56
Volume55,472
Average volume (3 months)103,606
Market cap$2.7B
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-143.26%
Earnings growth (this year)--
Earnings growth (next 5 years)-77.90%
Revenue growth (last year)-52.36%
P/E ratio--
Price/Sales51.41
Price/Book5.81

Competitors

 Today’s
change
Today’s
% change
ICPTIntercept Pharmaceut...+3.30+3.21%
RAREUltragenyx Pharmaceu...-1.22-1.70%
GWPHGW Pharmaceuticals P...-3.13-2.65%
PBHPrestige Brands Hold...+0.56+1.20%
Data as of 4:02pm ET, 12/09/2016

Financials

Next reporting dateMarch 3, 2017
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$43.7M
Annual profit (last year)-$130.7M
Net profit margin-299.29%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
Onno van de Stolpe
Chief Financial Officer
Bart Filius
Corporate headquarters
Mechelen, Brussels Region

Forecasts